Century Therapeutics (IPSC)
(Delayed Data from NSDQ)
$3.03 USD
+0.03 (1.00%)
Updated May 3, 2024 04:00 PM ET
After-Market: $3.06 +0.03 (0.99%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.50 |
EPS Last Quarter | -0.49 |
Last EPS Surprise | 12.50% |
ABR | 1.29 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.94 |
Next Year | -2.00 |
EPS (TTM) | -2.13 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.30M | 0.30M | 9.27M | 13.41M |
# of Estimates | 2 | 2 | 5 | 4 |
High Estimate | 0.50M | 0.50M | 30.97M | 44.25M |
Low Estimate | 0.10M | 0.10M | 0.40M | 0.40M |
Year ago Sales | 1.72M | 0.10M | 2.23M | 9.27M |
Year over Year Growth Est. | -82.56% | 200.00% | 314.95% | 44.62% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.50 | -0.49 | -1.94 | -2.00 |
# of Estimates | 3 | 3 | 4 | 4 |
Most Recent Consensus | -0.52 | -0.56 | -2.34 | -1.89 |
High Estimate | -0.45 | -0.39 | -1.60 | -1.42 |
Low Estimate | -0.53 | -0.56 | -2.34 | -2.87 |
Year ago EPS | -0.53 | -0.56 | -2.08 | -1.94 |
Year over Year Growth Est. | 5.66% | 12.50% | 6.73% | -3.35% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 1 | 1 |
Up Last 60 Days | 3 | 3 | 3 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.50 | -0.49 | -1.94 | -2.00 |
7 Days Ago | -0.50 | -0.49 | -1.94 | -2.00 |
30 Days Ago | -0.50 | -0.52 | -2.02 | -2.22 |
60 Days Ago | -0.63 | -0.64 | -2.40 | -1.42 |
90 Days Ago | -0.63 | -0.64 | -2.45 | -1.92 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.50 | -0.39 | -1.60 | -1.86 |
Zacks Consensus Estimate | -0.50 | -0.49 | -1.94 | -2.00 |
Earnings ESP | 0.00% | 20.41% | 17.31% | 7.25% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.49 | -0.55 | -0.56 | -0.53 | NA |
Estimate | -0.56 | -0.53 | -0.54 | -0.53 | NA |
Difference | 0.07 | -0.02 | -0.02 | 0.00 | 0.01 |
Surprise | 12.50% | -3.77% | -3.70% | 0.00% | 1.26% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more